🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
To determine what side effects and what clinical effect, if any, the admini...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00048555
Treatments Being Tested
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Withdrawn
Location
Northwest Alabama Cancer Center
Start Date
2007-09
Trial ID
NCT00577161
Treatments Being Tested
This study is a multicentric trial evaluating the efficacy of the RFM regim...
Status
Completed
Location
Service de médecine D - Maladies du Sang CHU Angers
Start Date
2001-04
Trial ID
NCT00169208
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
The use of R-CHOP, given every two weeks, will be associated with improveme...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2008-01-10
Trial ID
NCT00599170
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058